US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist
  • 5.160
  • +0.010+0.19%
Close Nov 4 16:00 ET
  • 5.160
  • 0.0000.00%
Post 16:00 ET
552.87MMarket Cap-4648P/E (TTM)

Tango Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
36.15%19.88M
12.23%6.47M
46.93%36.53M
-15.29%5.43M
55.09%10.73M
152.95%14.6M
0.14%5.77M
-32.89%24.86M
12.16%6.41M
1.96%6.92M
Operating revenue
36.15%19.88M
12.23%6.47M
46.93%36.53M
-15.29%5.43M
55.09%10.73M
152.95%14.6M
0.14%5.77M
-32.89%24.86M
12.16%6.41M
1.96%6.92M
Cost of revenue
Gross profit
Operating expense
30.60%49.43M
35.15%48.73M
10.87%150.7M
9.37%40.44M
-1.32%36.36M
22.19%37.85M
15.79%36.05M
42.74%135.93M
33.49%36.98M
39.79%36.84M
Selling and administrative expenses
17.43%10.77M
33.05%10.66M
18.24%35.5M
15.44%9.11M
13.71%9.21M
26.85%9.17M
17.72%8.01M
70.64%30.03M
30.02%7.89M
82.70%8.1M
-General and administrative expense
17.43%10.77M
33.05%10.66M
18.24%35.5M
15.44%9.11M
13.71%9.21M
26.85%9.17M
17.72%8.01M
70.64%30.03M
30.02%7.89M
82.70%8.1M
Research and development costs
34.82%38.65M
35.76%38.07M
8.77%115.2M
7.73%31.34M
-5.55%27.15M
20.77%28.67M
15.24%28.04M
36.41%105.91M
34.47%29.09M
31.11%28.74M
Operating profit
-27.12%-29.55M
-39.52%-42.26M
-2.79%-114.17M
-14.55%-35.01M
14.36%-25.63M
7.76%-23.25M
-19.33%-30.29M
-90.88%-111.07M
-39.04%-30.57M
-52.91%-29.92M
Net non-operating interest income expense
42.83%2.07M
107.07%2.2M
354.60%6.62M
278.34%2.24M
434.86%1.87M
388.22%1.45M
386.70%1.06M
194.14%1.46M
201.53%591K
284.62%350K
Non-operating interest income
42.83%2.07M
107.07%2.2M
354.60%6.62M
278.34%2.24M
434.86%1.87M
388.22%1.45M
386.70%1.06M
194.14%1.46M
201.53%591K
284.62%350K
Other net income (expense)
73.33%2M
79.46%2.18M
298.12%5.94M
113.13%2.06M
189.48%1.51M
2,202.00%1.15M
2,689.36%1.22M
702.02%1.49M
1,293.83%967K
1,146.00%523K
Other non- operating income (expenses)
73.33%2M
79.46%2.18M
298.12%5.94M
113.13%2.06M
189.48%1.51M
2,202.00%1.15M
2,689.36%1.22M
702.02%1.49M
1,293.83%967K
1,146.00%523K
Income before tax
-23.44%-25.49M
-35.23%-37.87M
6.02%-101.61M
-5.88%-30.72M
23.44%-22.24M
16.93%-20.65M
-11.11%-28.01M
-86.60%-108.12M
-32.65%-29.01M
-48.76%-29.05M
Income tax
1.56%65K
40K
148.15%134K
-7.84%47K
23K
2,033.33%64K
0
-81.51%54K
-71.19%51K
0
Net income
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
-48.29%-29.05M
Net income continuous Operations
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
-48.29%-29.05M
Minority interest income
Net income attributable to the parent company
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
-48.29%-29.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-23.38%-25.55M
-35.37%-37.91M
5.95%-101.74M
-5.86%-30.76M
23.36%-22.26M
16.69%-20.71M
-11.11%-28.01M
-85.76%-108.18M
-31.82%-29.06M
-48.29%-29.05M
Basic earnings per share
-4.35%-0.24
-9.37%-0.35
12.20%-1.08
9.09%-0.3
30.30%-0.23
17.86%-0.23
-10.34%-0.32
-30.85%-1.23
-32.00%-0.33
-17.86%-0.33
Diluted earnings per share
-4.35%-0.24
-9.37%-0.35
12.20%-1.08
9.09%-0.3
30.30%-0.23
17.86%-0.23
-10.34%-0.32
-30.85%-1.23
-32.00%-0.33
-17.86%-0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 36.15%19.88M12.23%6.47M46.93%36.53M-15.29%5.43M55.09%10.73M152.95%14.6M0.14%5.77M-32.89%24.86M12.16%6.41M1.96%6.92M
Operating revenue 36.15%19.88M12.23%6.47M46.93%36.53M-15.29%5.43M55.09%10.73M152.95%14.6M0.14%5.77M-32.89%24.86M12.16%6.41M1.96%6.92M
Cost of revenue
Gross profit
Operating expense 30.60%49.43M35.15%48.73M10.87%150.7M9.37%40.44M-1.32%36.36M22.19%37.85M15.79%36.05M42.74%135.93M33.49%36.98M39.79%36.84M
Selling and administrative expenses 17.43%10.77M33.05%10.66M18.24%35.5M15.44%9.11M13.71%9.21M26.85%9.17M17.72%8.01M70.64%30.03M30.02%7.89M82.70%8.1M
-General and administrative expense 17.43%10.77M33.05%10.66M18.24%35.5M15.44%9.11M13.71%9.21M26.85%9.17M17.72%8.01M70.64%30.03M30.02%7.89M82.70%8.1M
Research and development costs 34.82%38.65M35.76%38.07M8.77%115.2M7.73%31.34M-5.55%27.15M20.77%28.67M15.24%28.04M36.41%105.91M34.47%29.09M31.11%28.74M
Operating profit -27.12%-29.55M-39.52%-42.26M-2.79%-114.17M-14.55%-35.01M14.36%-25.63M7.76%-23.25M-19.33%-30.29M-90.88%-111.07M-39.04%-30.57M-52.91%-29.92M
Net non-operating interest income expense 42.83%2.07M107.07%2.2M354.60%6.62M278.34%2.24M434.86%1.87M388.22%1.45M386.70%1.06M194.14%1.46M201.53%591K284.62%350K
Non-operating interest income 42.83%2.07M107.07%2.2M354.60%6.62M278.34%2.24M434.86%1.87M388.22%1.45M386.70%1.06M194.14%1.46M201.53%591K284.62%350K
Other net income (expense) 73.33%2M79.46%2.18M298.12%5.94M113.13%2.06M189.48%1.51M2,202.00%1.15M2,689.36%1.22M702.02%1.49M1,293.83%967K1,146.00%523K
Other non- operating income (expenses) 73.33%2M79.46%2.18M298.12%5.94M113.13%2.06M189.48%1.51M2,202.00%1.15M2,689.36%1.22M702.02%1.49M1,293.83%967K1,146.00%523K
Income before tax -23.44%-25.49M-35.23%-37.87M6.02%-101.61M-5.88%-30.72M23.44%-22.24M16.93%-20.65M-11.11%-28.01M-86.60%-108.12M-32.65%-29.01M-48.76%-29.05M
Income tax 1.56%65K40K148.15%134K-7.84%47K23K2,033.33%64K0-81.51%54K-71.19%51K0
Net income -23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M-48.29%-29.05M
Net income continuous Operations -23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M-48.29%-29.05M
Minority interest income
Net income attributable to the parent company -23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M-48.29%-29.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -23.38%-25.55M-35.37%-37.91M5.95%-101.74M-5.86%-30.76M23.36%-22.26M16.69%-20.71M-11.11%-28.01M-85.76%-108.18M-31.82%-29.06M-48.29%-29.05M
Basic earnings per share -4.35%-0.24-9.37%-0.3512.20%-1.089.09%-0.330.30%-0.2317.86%-0.23-10.34%-0.32-30.85%-1.23-32.00%-0.33-17.86%-0.33
Diluted earnings per share -4.35%-0.24-9.37%-0.3512.20%-1.089.09%-0.330.30%-0.2317.86%-0.23-10.34%-0.32-30.85%-1.23-32.00%-0.33-17.86%-0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data